Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”
- PMID: 22493410
- DOI: 10.1001/archinternmed.2012.463
Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”
Comment on
-
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Arch Intern Med. 2012. PMID: 22493407 Review.
Similar articles
-
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.Arch Intern Med. 2012 May 14;172(9):686-94. doi: 10.1001/archinternmed.2012.262. Arch Intern Med. 2012. PMID: 22493407 Review.
-
Secondary cardiovascular prevention: omega-3 fatty acids ineffective.Prescrire Int. 2013 Sep;22(141):218. Prescrire Int. 2013. PMID: 24171221
-
The utility of omega-3 fatty acids in cardiovascular disease.Am J Ther. 2009 Sep-Oct;16(5):421-36. doi: 10.1097/MJT.0b013e3180a5f0bb. Am J Ther. 2009. PMID: 19092647 Review.
-
Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.Cell Biochem Biophys. 2015 May;72(1):77-81. doi: 10.1007/s12013-014-0407-5. Cell Biochem Biophys. 2015. PMID: 25427890 Review.
-
Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease.Evid Based Med. 2013 Aug;18(4):e33. doi: 10.1136/eb-2012-100960. Epub 2012 Nov 17. Evid Based Med. 2013. PMID: 23161504 No abstract available.
Cited by
-
Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity's Metabolic Consequences.Medicines (Basel). 2019 Sep 9;6(3):94. doi: 10.3390/medicines6030094. Medicines (Basel). 2019. PMID: 31505825 Free PMC article. Review.
-
Bioactive products formed in humans from fish oils.J Lipid Res. 2015 Sep;56(9):1808-20. doi: 10.1194/jlr.M060392. Epub 2015 Jul 15. J Lipid Res. 2015. PMID: 26180051 Free PMC article. Clinical Trial.
-
The pathophysiology of hypertension in patients with obesity.Nat Rev Endocrinol. 2014 Jun;10(6):364-76. doi: 10.1038/nrendo.2014.44. Epub 2014 Apr 15. Nat Rev Endocrinol. 2014. PMID: 24732974 Free PMC article. Review.
-
Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality.Am J Epidemiol. 2014 Mar 15;179(6):710-20. doi: 10.1093/aje/kwt326. Epub 2014 Feb 3. Am J Epidemiol. 2014. PMID: 24496442 Free PMC article.
-
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8. Lancet. 2012. PMID: 23245609 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
